Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

A woman with severe angioedema improved significantly after treatment with rituximab.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Skin conditions can signal heart issues, highlighting the need for integrated care.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Effective symptom management in IBD improves quality of life and prevents complications.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.